Ian J. Frew
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 12
- Cancer Genomics and Diagnostics 3
- Molecular Biology top 5%
- Renal and related cancers 14
- Epigenetics and DNA Methylation 8
- Ubiquitin and proteasome pathways 4
- Genetics top 5%
- Genetic and Kidney Cyst Diseases 9
-
- Renal cell carcinoma treatment 15
- Cell Biology top 5%
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Holger MochWilhelm KrekClaudio R. ThomaDavid D.L. BowtellPeter J. WildM. MontaniPeter SchramlStrahil Georgiev
- Journals
- Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- SwitzerlandGermanyAustralia
In The Last Decade
Ian J. Frew
52 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 1.0k
- Molecular Biology 1.9k
- Genetics 538
- Pulmonary and Respiratory Medicine 597
- Cell Biology 271
Countries citing papers authored by Ian J. Frew
This map shows the geographic impact of Ian J. Frew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian J. Frew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian J. Frew more than expected).
Fields of papers citing papers by Ian J. Frew
This network shows the impact of papers produced by Ian J. Frew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian J. Frew. The network helps show where Ian J. Frew may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian J. Frew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 2 | |
| 10 | 2017 | 23 | |
| 11 | 2017 | 3 | |
| 12 | 2013 | 13 | |
| 13 | 2012 | 52 | |
| 14 | 2008 | 38 | |
| 15 | 2008 | 124 | |
| 16 | 2007 | 48 | |
| 17 | 2004 | 338 | |
| 18 | 2004 | 9 | |
| 19 | 2002 | 91 | |
| 20 | 1999 | 15 |
About Ian J. Frew
Ian J. Frew is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 55 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Renal and related cancers (14 papers), Cancer, Hypoxia, and Metabolism (12 papers), Genetic and Kidney Cyst Diseases (9 papers), Epigenetics and DNA Methylation (8 papers), Ubiquitin and proteasome pathways (4 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.9k citations) and Genetics (538 citations). Ian J. Frew has collaborated with scholars based in Switzerland, Germany and Australia. Frequent co-authors include Holger Moch, Wilhelm Krek, Claudio R. Thoma, David D.L. Bowtell, Peter J. Wild, M. Montani, Peter Schraml, Strahil Georgiev, Sabine Harlander and Christian R. Hoerner. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.